Industry
Pharmaceuticals
Topic
All Topics
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Pharmaceuticals
... aging and disease to tackle everything from Alzheimer's to cancer. (Fortune) INDICATIONS Pfizer snags another approval for a copycat of J&J's best-selling drug. Drug giant ...
... Photo Teva A Teva factory in Hungary. The company, the world’s largest maker of ...
... Walt Disney, 21st Century Fox, Roku and Tintri. American depository receipts of Teva rose 18% in premarket trading Thursday after the Israel-based company said it ...
... Teva Pharmaceutical Industries announced some of the most sweeping job cuts in the drug ...
... Teva Pharmaceutical plans to reduce its workforce by 25 percent and suspend its ...
... Cambridge, Massachusetts-based Relay Therapeutics, a biotech company, has closed $63 million in Series B financing. ...
... US and EU and associated with 10-year mortality of 40-60% Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development ...
... CITY chatter swirled around pharma company Vectura yesterday amid speculation that one of its partners such as Novartis could ...
... CANADIAN RESULTS GLG Life Tech (TSX:GLG) reported loss for the quarter-ended 30 September 2017 of CAD3.8m ...
... ORIGINAL ANNOUNCEMENT [Text] VICTORIA, British Columbia, Dec. 13, 2017 -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (the "Company") is issuing this press release in response ...
... ORIGINAL ANNOUNCEMENT [Text] RICHMOND HILL, ONTARIO--(Marketwired - Dec. 13, 2017) - Helix BioPharma Corp. (TSX:HBP) (FRANKFURT:HBP), an immuno-oncology company developing drug candidates for the prevention ...
... largest pharmaceutical wholesaler and distributor to pharmacies and hospitals after acquiring the Symbion business in mid-2013 for $NZ1.1 billion. John Cullity, the chief financial officer ...
... gauge patients' day to day health with cold, hard data. (MobiHealthNews) INDICATIONS Novartis is selling off some of its generics. Swiss pharma giant Novartis' generics ...
... food to therapeutic products include: NightFood Holdings, Inc. (OTC: NGTF), INSYS Therapeutics, Inc. (NASDAQ: INSY), Medical Marijuana, Inc. (OTC: MJNA), Lexaria Bioscience Corp. (OTC: LXRP), ...
... While Australiahasfacedone of the harshest influenza seasons of decades[1], Eurocine Vaccines prepares for the next phase of development, a second clinical study ...
... hour. In June 2017, Brooks won a $235 million jury verdict for GlaxoSmithKline (GSK) against Teva Pharmaceuticals in a patent infringement lawsuit involving GSK's highly ...
... Capricor Therapeutics(NASDAQ: CAPR) today announced that the U.S. Patent and Trademark Office has issued ...
... timely information, WallStEquities.com has issued free tailored Stock Review on SPPI, JAZZ, ITCI, and DERM which is a click away athttp://www.wallstequities.com/registration. On Tuesday, December 12, ...
... and Global Therapeutic Group Head for Oncology and Personalized Genetic Health at Genzyme Corporation, where he was responsible for leading clinical development teams for all ...
... itsCryoStor® cell freeze media andHypoThermosol® cell storage and shipping media to Iovance Biotherapeutics, Inc. ("Iovance") (NASDAQ: IOVA). Iovance is currently conducting several clinical trials for ...
... members with timely information, WallStEquities.com has issued free tailored Stock Review on VSAR, AKRX, RIGL, and MDCO which is a click away athttp://www.wallstequities.com/registration. WallStEquities.com revisits ...
... Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced updates related to its collaboration programs with Sanofi, ...
... Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) ("Dicerna" or the "Company"), a leading developer of investigational ribonucleic ...
... Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that the European Medicines Agency (EMA) ...
... Robbins Arroyo LLP is investigating whether certain officers and directors of Ophthotech Corporation (NasdaqGS: OPHT) breached their fiduciary duties to shareholders. Ophthotech is a biopharmaceutical ...
... Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will issue a press release ...
... ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of ...
Incuron LLC, Alkermes Plc, and 2 more
... for the treatment of various indications include Alkermes Plc, Reata Pharmaceuticals, Inc., Incuron LLC, Catabasis Pharmaceuticals, Inc. and others. NF-kB Inhibitors Therapeutics Pipeline Analysis: By ...
... the treatment of myasthenia gravis include Alexion Pharmaceuticals, Inc., CSL Behring LLC, Novartis AG and others. Key Topics Covered: 1. Research Background 2. Research Methodology ...
... Zoetis Inc. (NYSE:ZTS) will participate in the 36th Annual J.P. Morgan Healthcare Conference on ...
... Principia Biopharma, a private, clinical-stage biopharmaceutical company, today announced that it has initiated ...
... Sobi, a pioneering international biopharmaceutical company dedicated to rare and difficult-to-treat diseases, is ...
... in a $300 million license deal for allergy in humans to Astellas Pharma, Inc. Following the Astellas transaction, the Company turned its attention back to ...
... X-Chem, Inc. (X-Chem), and Abilita Bio, Inc. (Abilita), both privately held biotechnology companies, announce ...
... Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology Company with fully integrated commercial and drug development ...
... Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a late-stage clinical oncology company advancing novel product candidates based ...
... Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi presents R&D strategy and innovative pipeline -- ...
... STOCKHOLM, December 13, 2017. Karolinska Development announces today the divestment of its holding in Lipidor AB. In ...
... (Nasdaq:FLXN) today announced it has entered into a definitive agreement with GeneQuine Biotherapeutics GmbH to acquire the global rights to GQ-203. As part of the ...
... and KING OF PRUSSIA, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and ...
... EDISON, N.J., Dec. 13, 2017 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of ...
... inflammatory gastrointestinal disease SAN CARLOS, Calif., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Allakos Inc., a private, clinical-stage biopharmaceutical company focused on the development of antibodies ...
... LONDON, Dec. 13, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) ("GW" or "the Company"), a biopharmaceutical company focused on discovering, ...
... MedImmune - SAN CARLOS, Calif., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating ...
... LAKE CITY and YOKOHAMA, Japan, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Q Therapeutics, Inc., a developer of clinical-stage cell therapies for central nervous system (CNS) ...
... Five years after bagging a modest $30 million in series A financing, Allakos has picked up a hefty $100 million from the likes of New ...
... RICHMOND HILL, ONTARIO--(Marketwired - Dec. 13, 2017) - Helix BioPharma Corp. (TSX:HBP) (FRANKFURT:HBP), an immuno-oncology company developing drug candidates for the prevention ...
... IRVINE, CA - Cannabis Science, Inc. (OTC Pink: CBIS), a U.S. company specializing in the development of ...
... Copenhagen, Denmark - Genmab A/S (Nasdaq Copenhagen: GEN) will hold a R&D Update today, December 11, ...
... Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline ...
... NEW YORK - Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) ('Actinium' or 'the Company') announced results from an ...
... Health, is pleased to announce finalization and signature of the contract with Libbs, the Women's Health leader in Brazil, for an exclusive license to Estelle ...
... Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today ...
... TOKYO - Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that the phase III IMmotion151 study met ...
... Berlin - Bayer's development partner, Janssen Research & Development, LLC has submitted a supplemental New Drug Application (sNDA) to the ...
... ATLANTA and RARITAN, NJ - Today, Janssen Research & Development, LLC (Janssen) announced results of a pooled analysis of relapsed/refractory (r/r) ...
... RARITAN, NJ - Janssen Research & Development, LLC (Janssen) today announced it has submitted a supplemental New Drug ...
... GlaxoSmithKline plc (LSE/NYSE: GSK) today presented promising new data from the dose expansion ...
... perks provided to its then-CEO and then-CFO. According to the SEC, Tennessee-based Provectus lacked sufficient controls surrounding the reporting and disclosure of travel and entertainment ...
... immune system to treat cancer. Prior to Juno, Dr. Mohler co-founded Trubion Pharmaceuticals Inc., a biopharmaceutical company focused on the development of novel protein therapeutics ...
... as COO and CFO. Atlas Genetics is backed by Novartis Venture Fund, Consort Medical, Wondfo Biotech, LSP Venture Capital, BB Biotech, Johnson & Johnson Innovation, ...
... the business, according to the Securities and Exchange Commission. Craig Dees and Provectus’ former finance chief Peter Culpepper have both been charged in connection with ...
... slide created by dealmaking debt and generics pricing pressure. The company grabbed Allergan’s generics unit last year in a $40.5 billion deal to revive generics ...
... Daiichi Sankyo has tapped Vernalis for its drug discovery expertise. The agreement will ...
... TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Aphria Inc. ("Aphria" or the "Company") (TSX:APH) is pleased to announce that it has ...
... date for the closing of the Companys proposed reverse merger with Innovate Biopharmaceuticals, Inc. (Innovate). The Panels granting of the Companys request for continued listing ...
... Centre for Inflammation Research, which also announces today GBP2m of investment from GlaxoSmithKline. The MCCIR, established in 2012, is unique collaboration which has established a ...
... CANADIAN DAILY STOCK REPORT Corporate Wire Date: 13 December 2017 02:00 EST Acerus Pharmaceuticals (Canadian:ASP) director Mark Lievonen, has been granted options on 200,000 shares ...
... DAILY STOCK REPORT Corporate Wire Date: 13 December 2017 02:02 EST Aequus Pharmaceuticals Inc. (Canadian:AQS) director Chris Clark, has been granted options on 100,000 shares ...
... her daughter, who suffers from seizures, developmental delays and speech impairment. Ovid Therapeutics Inc.'s medicine for Angelman syndrome is now in clinical trials. "We need ...
... Funds to be Used for Expansion of Radient Facility and Operations TSX: ACB TSX-V: RTI VANCOUVER and EDMONTON, Dec. 12, 2017 /CNW/ - Aurora Cannabis ...
... Canada NewsWire LAVAL, QC, Dec. 12, 2017 - Proceeds to Support Advancing BLU-5937 for Chronic Cough into Clinical Testing - /NOT FOR DISTRIBUTION TO UNITED ...
Want to see the full history of news? Upgrade to RelSci Professional now!
Start My Free Trial